Clinical Convergence®: Creating a Framework for Personalized Management in the Treatment of Children with Asthma

Program Overview

An Online IME Intervention Featuring Clinician and Patient Faculty and a Decision Support Aid for Practice Application Experts in the management of children with asthma discuss the origins of this disorder, challenges associated with the management of this population, current management guidelines, and the role of biologic therapy in the treatment of individual patients. Conversations with two pediatric patients with asthma and their parents are included to provide a real-world perspective on the management of this disease.

Credit Expired
CE Credit Expired
Expires: November 12, 2021

Target Audience

This activity is designed for clinicians (MD/DO, NP, PA) practicing in the specialties of allergy/immunology, pediatrics, and pulmonology, who diagnose and manage asthma in children.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Identify barriers to the optimal management of children with asthma
  • Apply established guidelines and algorithms when managing children with asthma
  • Assess current data on approved and emerging biologic therapies for the treatment of children with asthma
  • Recognize that children with moderate-to-severe asthma may benefit from treatment with a biologic therapy

Activity Faculty

Jonathan Corren, MD

Jonathan Corren, MD

Associate Clinical Professor, Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA

Michael E. Wechsler, MD, MMSc

Michael E. Wechsler, MD, MSSc

Professor, Medicine
Director, Cohen Family NJH Asthma Institute
Director, Asthma Program, National Jewish Health
Division of Pulmonary, Critical Care and Sleep Medicine
Department of Medicine
National Jewish Health and University of Colorado School of Medicine
Aurora, CO

Supporter Statement

Provider Statement

Disclosure of Financial Relationships

Faculty

Planners and Managers

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | www.RMEI.com | (866) 770-RMEI

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources